Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
61 |
Employees |
56 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-93 |
Cash Flow (TTM) (Millions $) |
-62 |
Capital Exp. (TTM) (Millions $) |
0 |
Surface Oncology Inc
Surface Oncology Inc. is a biotechnology company that specializes in the development of cancer immunotherapies. The company's primary focus is on the discovery and development of novel antibody-based treatments for various types of cancer. Surface Oncology aims to leverage the body's immune system to fight cancer by targeting specific immune checkpoints and pathways involved in tumor growth and suppression. The company's pipeline includes multiple candidates currently in preclinical and clinical development stages, with a focus on developing therapies with the potential to improve patient outcomes.
Company Address: 50 Hampshire Street Cambridge 2139 MA
Company Phone Number: 714-4096 Stock Exchange / Ticker: NASDAQ SURF
|